TEST KIT, CHLAMYDIA TRA

Solicitation SPE2DS-26-T-460W is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one Chlamydia trachomatis detection test kit under NAICS 325413. The required kit is a qualitative direct immunofluorescence test designed for detecting chlamydia in human urogenital and ophthalmic specimens and confirming chlamydia in cell culture. Each kit is designed for 50 tests and must include two positive control slides, mounting fluid, chlamydia test reagent, and instructions for use. The delivery is required by September 23, 2026, to the AFMEDCOM facility in San Antonio, Texas, with a submission deadline for quotes of September 28, 2026. The contract mandates destination inspection and acceptance, with payment processing handled through the Wide Area WorkFlow system. Packaging must be commercial and adhere to Medical Marking Standard No. 1, requiring labels to display the date of manufacture, expiration or retest date, and the contract or lot number. Compliance requirements include adherence to the Buy American Act, the Berry Amendment, and FDA regulations for labeling and Good Manufacturing Practices. Additionally, the contractor must comply with cybersecurity standards under DFARS 252.204-7012 and hazardous material labeling standards per 29 CFR 1910.1200.